Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06425731 · ClinicalTrials.gov registry record · NA

Dance and Energy Expenditure Among Adults With Parkinson's

A NA study of Parkinson Disease, sponsored by Northeastern University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06425731: Recruiting NA study of Parkinson Disease, sponsored by Northeastern University.

NCT06425731 is a NA study of Parkinson Disease that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 60 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06425731, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Northeastern University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The first purpose of the study is to develop and test new methods for quantifying dance among adults with a diagnosis of Parkinson's using various kinds of cameras, wearable activity monitors, and questionnaires. The second reason we are conducting the study is to better understand the relationship between the intensity of dance classes specifically designed for adults with Parkinson's and individual-level factors like the kinds of routine activities one does beyond dancing and one's health status. Participants in the study may be asked to engage in any of the following activities: * complete a small number of assessments on their physical and cognitive functioning * complete their routine group-based dance classes, specifically designed for adults with a diagnosis of Parkinson's, while being recorded Depending upon the group that a participant joins, one may also be asked to: * wear an activity monitor on their waist while engaged in their daily business as usual for nine (9) days * complete an iDXA scan * describe their perceptions on how the use of technology can integrated into their dancing

Primary Outcome

The rate of oxygen uptake during a 60-min dance session

Conditions Studied

Interventions

  • OTHER Fasting
  • OTHER No Intervention

Study Locations (1)

Massachusetts

  • Northeastern University - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-07-01
Est. Completion 2026-01-15
Phase NA
Northeastern University

39 total trials

What NCT06425731 shows while recruiting

NCT06425731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Fasting is the first listed.

NCT06425731 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06425731 about?

NCT06425731 is a clinical study titled "Dance and Energy Expenditure Among Adults With Parkinson's". The first purpose of the study is to develop and test new methods for quantifying dance among adults with a diagnosis of Parkinson's using various kinds of cameras, wearable activity monitors, and questionnaires. The second reason we are conducting the study is to better understand the relationship ...

What is the current status of trial NCT06425731?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-07-01. Estimated completion is 2026-01-15.

What conditions does trial NCT06425731 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06425731?

The interventions under investigation include: Fasting (OTHER), No Intervention (OTHER).

Who is sponsoring clinical trial NCT06425731?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06425731 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06425731's enrollment target sits among peer trials

60 125th of 297 higher than 154 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

  • NCT02114450 · 60 participants · NA

    Human-Machine System for the H2 Lower Limb Exoskeleton

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06425731, the US trial registry maintained by the National Library of Medicine. NCT06425731 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.